News Breaks |
|
|
| February 4, 2013 |
| 06:08 EDT |  | MDCO, ALNY | The Medicines Co., Alnylam form strategic alliance to develop RNAi Therapeutics
The Medicines Company (MDCO) and Alnylam (ALNY) announced that they have formed an exclusive global alliance for the development and commercialization of Alnylam's ALN-PCS RNAi therapeutic program for the treatment of hypercholesterolemia. Under this alliance, The Medicines Company and Alnylam intend to collaborate on the advancement of the ALN-PCS program. Alnylam will continue the program for an estimated one to two years to complete certain pre-clinical and Phase I clinical studies. The Medicines Company is responsible for leading and funding development from Phase II forward and commercializing the ALN-PCS program if successful. Under the terms of the agreement, The Medicines Company will make an upfront cash payment of $25M to Alnylam. Alnylam may also receive potential development and commercial milestone payments of up to $180M. Alnylam will be eligible to receive scaled double-digit royalties on global products sales of ALN-PCS products. |
|
|
News For MDCO;ALNY From The Last 14 Days Check below for free stories on MDCO;ALNY the last two weeks. |
|
|
| May 17, 2013 |
| 08:04 EDT | | ALNY | Alnylam announces proof-of-concept data from RNAi program
 Subscribe for More Information |
|
| May 16, 2013 |
| 07:29 EDT |  | ALNY | Leerink to host a bus tour
Boston Biopharma Bus Tour travels throughout Boston on May 16-17. |
|
| May 14, 2013 |
| 08:43 EDT |  | ALNY | Alnylam has multiple upcoming positive catalysts, says JMP Securities
JMP Securities believes that Alnylam will have multiple positive data catalysts over the next two months. The firm thinks that upcoming data and presentations will enhance the company's positioning and perception of its pipeline, and it keeps an Outperform rating on the shares. |
|
| May 6, 2013 |
| 16:04 EDT | | ALNY | Alnylam sees ending 2013 with over $320M in cash, equivalents
Subscribe for More Information |
|
| 16:03 EDT |  | ALNY | Alnylam reports Q1 EPS (15c), consensus (29c)
Subscribe for More Information |
|
| 07:34 EDT | | MDCO | Conference Forum to host a summit
Subscribe for More Information |
|
|
|
|
|
